CISEN PHARMACEUTICAL CO.,LTD.
|
For the treatment of patients with B-cell chronic lymphocytic leukemia (CLL) who have been treated with at least one standard regimen containing alkylating agents and whose disease has not improved or continues to progress during or after treatment.
Specification: 50mg |
Send Inquiry
|